Gunther Birznieks
SVP, Business Development · Vanda Pharmaceuticals Inc.
- 2026
- Mar 4, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gunther Birznieks files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mihael Hristos Polymeropoulos - $1.28M in VNDA purchases and sales in the last 12 months
- Kevin Patrick Moran - $351K in VNDA purchases and sales in the last 12 months
- Timothy Williams - $351K in VNDA purchases and sales in the last 12 months
- Joakim Wijkstrom - $255K in VNDA purchases and sales in the last 12 months
- Tage Honore - $241K in VNDA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gunther Birznieks?
Gunther Birznieks is a corporate insider, tracked as SVP, Business Development of Vanda Pharmaceuticals Inc. (VNDA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Gunther Birznieks last file a Form 4?
The most recent primary Form 4 on record is dated 4 March 2026, one of 2 filings going back to 2026.
Has Gunther Birznieks been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($351K) across all tracked filings.
